Upstream Medical Technologies Ltd (UMT) is a biomarker based testing developer that markets novel biomarkers for cardiac diagnosis. The company offers patented pipeline of products such as BNP-sp, used for diagnoses of unstable angina, CVD, ACS, and others. It provides pipe line product such as Ghr-sp-Pne diagnoses heart failure in the presence of pneumonia; and EPO-sp for detection of kidney failure. It offers products to identify comorbid disease associated with kidney failure, metabolic disease, sepsis and atrial fibrillation, among others. The company develops biomarker-based testing for diagnoses of heart disease and associated clinical complications. UMT is headquartered in Christchurch, New Zealand.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Upstream Medical Technologies Ltd
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Upstream Medical Technologies Ltd Company Overview
Upstream Medical Technologies Ltd Company Snapshot
Upstream Medical Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
Upstream Medical Technologies Ltd – Pipeline Analysis Overview
Upstream Medical Technologies Ltd - Key Facts
Upstream Medical Technologies Ltd - Major Products and Services
Upstream Medical Technologies Ltd Pipeline Products by Development Stage
Upstream Medical Technologies Ltd Pipeline Products Overview
CNP-sp Test - Heart Disease
CNP-sp Test - Heart Disease Product Overview
CRP-sp Assay - Heart Failure
CRP-sp Assay - Heart Failure Product Overview
EPO-sp Test
EPO-sp Test Product Overview
GH Assay - Heart Failure
GH Assay - Heart Failure Product Overview
Ghr-sp Test - Heart Disease
Ghr-sp Test - Heart Disease Product Overview
Ghr-sp-Pne Test - Heart Failure
Ghr-sp-Pne Test - Heart Failure Product Overview
IGFs Assay - Heart Failure
IGFs Assay - Heart Failure Product Overview
INS-sp Test - Heart failure
INS-sp Test - Heart failure Product Overview
KIM-1sp Assay - Heart Failure
KIM-1sp Assay - Heart Failure Product Overview
NGAL-sp Test - Heart Failure
NGAL-sp Test - Heart Failure Product Overview
PSA-sp Assay - Heart Failure
PSA-sp Assay - Heart Failure Product Overview
TnTuORF Test - Acute Coronary Syndrome
TnTuORF Test - Acute Coronary Syndrome Product Overview
TSH Assay - Heart Failure
TSH Assay - Heart Failure Product Overview
UARatio Test - Angina
UARatio Test - Angina Product Overview
Upstream Medical Technologies Ltd - Key Competitors
Upstream Medical Technologies Ltd - Key Employees
Upstream Medical Technologies Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Upstream Medical Technologies Ltd, Recent Developments
May 15, 2017: Upstream Medical Technologies Provides Update on UARatio Test - Angina
Jul 08, 2016: Upstream Medical Technologies: Dr Jim Januzzi accepts appointment to Scientific Advisory Board
Jun 02, 2016: Professor Mark Richards accepts appointment to Scientific Advisory Board of Upstream Medical Technologies
Oct 28, 2015: Breakthrough Medical Research Company Formed
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Upstream Medical Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Upstream Medical Technologies Ltd Pipeline Products by Equipment Type
Table 3: Upstream Medical Technologies Ltd Pipeline Products by Indication
Table 4: Upstream Medical Technologies Ltd, Key Facts
Table 5: Upstream Medical Technologies Ltd, Major Products and Services
Table 6: Upstream Medical Technologies Ltd Number of Pipeline Products by Development Stage
Table 7: Upstream Medical Technologies Ltd Pipeline Products Summary by Development Stage
Table 8: CNP-sp Test - Heart Disease - Product Status
Table 9: CNP-sp Test - Heart Disease - Product Description
Table 10: CRP-sp Assay - Heart Failure - Product Status